Cost-effectiveness analysis of unsafe abortion and alternative first-trimester pregnancy termination strategies in nigeria and Ghana.

dc.contributor.authorHu, D.
dc.contributor.authorGrossman, D.
dc.contributor.authorLevin, C.
dc.contributor.authorBlanchard, K.
dc.contributor.authorAdanu, R.
dc.date.accessioned2013-06-18T12:45:06Z
dc.date.accessioned2017-10-16T12:24:08Z
dc.date.available2013-06-18T12:45:06Z
dc.date.available2017-10-16T12:24:08Z
dc.date.issued2010-06
dc.description.abstractTo explore the policy implications of increasing access to safe abortion in Nigeria and Ghana, we developed a computer-based decision analytic model which simulates induced abortion and its potential complications in a cohort of women, and comparatively assessed the cost-effectiveness of unsafe abortion and three first-trimester abortion modalities: hospital-based dilatation and curettage, hospital- and clinic-based manual vacuum aspiration (MVA), and medical abortion using misoprostol (MA). Assuming all modalities are equally available, clinic-based MVA is the most cost-effective option in Nigeria. If clinic-based MVA is not available, MA is the next best strategy. Conversely, in Ghana, MA is the most cost-effective strategy, followed by clinic-based MVA if MA is not available. From a real world policy perspective, increasing access to safe abortion in favor over unsafe abortion is the single most important factor in saving lives and societal costs, and is more influential than the actual choice of safe abortion modality.en_US
dc.identifier.citation26. Hu, D., Grossman, D., Levin, C., Blanchard, Goldie, S. J. K., Adanu, R., & (2010). Cost-effectiveness analysis of unsafe abortion and alternative first-trimester pregnancy termination strategies in nigeria and Ghana. African Journal of Reproductive Health, 14(2), 85-103en_US
dc.identifier.issn11184841
dc.identifier.urihttp://197.255.68.203/handle/123456789/3492
dc.language.isoenen_US
dc.publisherAfrican Journal of Reproductive Healthen_US
dc.subjectIndexed keywords EMTREE drug terms: abortive agent; misoprostol EMTREE medical terms: article; cost benefit analysis; curettage; decision support system; economics; female; first trimester pregnancy; Ghana; human; induced abortion; Nigeria; pregnancy; probability MeSH: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Cost-Benefit Analysis; Decision Support Techniques; Dilatation and Curettage; Female; Ghana; Humans; Markov Chains; Misoprostol; Nigeria; Pregnancy; Pregnancy Trimester, First; Vacuum Curettageen_US
dc.titleCost-effectiveness analysis of unsafe abortion and alternative first-trimester pregnancy termination strategies in nigeria and Ghana.en_US
dc.typeArticleen_US

Files

License bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.82 KB
Format:
Item-specific license agreed upon to submission
Description:
Loading...
Thumbnail Image
Name:
license.txt
Size:
0 B
Format:
Item-specific license agreed upon to submission
Description: